Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study

Clinical trial NCT07163611 · RECRUITING

Trial details

NCT number: NCT07163611
Sponsor: Radboud University Medical Center
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Membranous Nephropathy - PLA2R Induced

Start date: 2025-10-01
Primary completion: 2028-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.